HuagongsheHuagongshe Chemistry Print Report · For research reference only
Triethylamine → Revaprazan Hydrochloride
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 4-Chloro-N-(4-fluorophenyl)-5,6-dimethylpyrimidin-2-amine | HCID 9992376 | — |
| Reactant | (R)-1-Methyl-1,2,3,4-tetrahydroisoquinoline | HCID 11084033 | — |
| Reactant | (R)-(+)-5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine | HCID 40462255 | — |
| Solvent | Ethylene Glycol | HCID 174 | — |
| Product | Revaprazan Hydrochloride | HCID 204103 | 81.1% |
Reaction Steps
23 ml of triethylamine and 16 g (108.5 mmole) of (R)-(+)-1-methyl-1,2,3,4-tetrahydroisoquinoline as prepared in Example 10 were added to 75 ml of ethylene glycol. 25.7 g (101.8 mmole) of 4-chloro-2-(4-fluorophenylamino)-5,6-dimethylpyrimidine was added thereto and the mixture thereby obtained was reacted at 135° C. for 28 hours under refluxing to prepare (R)-(+)-5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine. This product was treated according to the procedure detailed in Example 24 to obtain 33 g of purified 5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)-pyrimidine hydrochloride.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06252076B1 |
| Source dataset | uspto-grants-2001_06 |
| ORD ID | ord-871a84ffabe747979fc56e418c479272 |
| Source note | uspto-grants-2001_06 |